Procognitive restoration of PV neuron plasticity in neurodevelopmental disorders

A recent study published in Nature reveals new insights into the potential for restoring cognitive function in individuals with neurodevelopmental disorders (NDDs) by targeting specific cellular mechanisms within the hippocampus. Researchers have identified key regulators, termed "experience-dependent plasticity genes", that could play a pivotal role in reversing some of the neurological impairments associated with conditions such as autism spectrum disorder (ASD), bipolar disorder, schizophrenia, and epilepsy. These findings suggest that even in adulthood, certain aspects of brain plasticity remain intact and can potentially be harnessed for therapeutic purposes. The research focuses on parvalbumin-expressing interneurons (PV INs) located in the dentate gyrus (DG), CA3/CA2 circuit of the hippocampus. These neurons are essential for regulating memory encoding, storage, retrieval, and routing through their ability to modulate the activity of principal neurons (PNS) via feedforward inhibition. This mechanism influences the synchronization of PN activity, forming ensembles necessary for generating network oscillations that facilitate both intra-hippocampal and cross-regional communication within larger brain networks involving the cortex and subcortex. Experience plays a critical role in shaping the functional properties of PV INs. During the early postnatal period, exposure to environmental stimuli refines hippocampal circuitry, influencing long-term cognitive outcomes. However, disruptions in this process, often linked to genetic risk factors, can lead to maladaptive neural functions, cognitive impairments, and seizures characteristic of various NDDs. The study highlights how genetic vulnerabilities may interfere with the normal experience-driven refinement of inhibition mediated by PV INs, thereby contributing to the pathophysiology of these disorders. Despite growing understanding of the molecular mechanisms governing PV IN identity and plasticity in the cortex, much remains unknown regarding the developmental regulators of hippocampal PV IN properties. The researchers emphasize that while there is considerable knowledge about transcription factors and epigenetic regulators that influence synaptic physiology and connectivity, information on their roles in adult hippocampal PV IN plasticity is limited. Intriguingly, the study shows that PV INs in the adult hippocampus still retain the capacity for experience-dependent plasticity. Learning and social experiences can enhance excitatory synaptic inputs onto these neurons, triggering changes that increase feedforward inhibition in DG, CA3/CA2 circuits. This, in turn, supports spatial and social memory by boosting intrinsic excitability and inhibitory synapses on CA3/CA2 PNs. At the network level, this enhanced inhibition helps stabilize and contextualize neuronal ensembles during memory consolidation, promoting coherent network oscillations. Building on prior studies, the researchers screened for cell-autonomous regulators of experience-dependent plasticity in the adult CA3/CA2 circuit. They identified several candidate regulators, including transcription factors and epigenetic modifiers, which are encoded by genes known to carry high confidence as risk factors for NDDs and epilepsies. The team tested whether restoring experience-dependent PV IN plasticity in the adult hippocampus using a commonly used NDD risk mouse model would be sufficient to reverse developmental deficits in circuitry, ensemble specificity, sharp-wave ripple (SWR) properties, seizures, and cognitive function. The implications of this research extend beyond theoretical neuroscience. If validated in human trials, these findings could pave the way for novel therapeutic strategies aimed at enhancing or restoring hippocampal plasticity in affected individuals. Such interventions might involve pharmacological agents targeting the identified transcription factors or epigenetic regulators, or behavioral therapies designed to stimulate the very experience-dependent processes that promote PV IN plasticity. Further investigation is needed to confirm these results in clinical settings and to determine the safety and efficacy of potential treatments. Nonetheless, the discovery of these regulators marks a significant step forward in understanding the complex interplay between genetics, environment, and brain plasticity in neurodevelopmental disorders.